No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

JN White Introduces the SnaggleClaw™

Editor: What To Know

  • When asked why the firm continues to expand into new PPE products, JN White® President, Jason Aymerich, explains, “JN White® continues to innovate where the market has a need.
  • In addition, the tool contains an antimicrobial coating that offers an additional layer of defense against pathogens.
  • The JN White ®  SnaggleClaw™is to be used in situations where an individual risks exposure to COVID-19.

J.N. White Associates, Inc. (announced today that it is launching the SnaggleClaw™: a new multipurpose, touchless tool that limits exposure to pathogens.

The JN White ®  SnaggleClaw™is to be used in situations where an individual risks exposure to COVID-19.

This tool provides a safer alternative to touching in everyday activities, such as operating touchscreens, keypads and door handles. In addition, the tool contains an antimicrobial coating that offers an additional layer of defense against pathogens.

JN White® is an ISO 9001:2015 and ITAR-certified custom manufacturer specializing in the design and production of membrane switches, graphic overlays and custom labels. The company works with a wide range of global companies in many industries including military/DoD, medical devices and appliances. In response to the coronavirus pandemic, JN White® moved into the development and production of Personal Protective Equipment (PPE).

When asked why the firm continues to expand into new PPE products, JN White® President, Jason Aymerich, explains, “JN White® continues to innovate where the market has a need.  Providing solutions in the PPE space furthers the firm’s commitment to helping our country stay strong.”

SplatterGuard and SnaggleClaw are trademarks of J.N. White Associates, Inc. JN White and Precision Answers are registered trademarks of J.N. White Associates, Inc. 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy